Innovation has been described as 'change that creates a new dimension for performance' as well as being about 'getting new ideas adopted'.

Synexus believes that the key to innovation is not all about the idea, but putting those ideas in practice in a way which adds value.

The Synexus hub model is exactly that. An example of innovation which will add significant value and revolutionises the business of clinical trials.

• There are more than 10,000 currently on trials with Synexus
• In a prostate cancer trial Synexus undertook more than 44,000 PSA tests and 2,000 prostate biopsies 
• In a recent CV outcome study Synexus randomised over 3000 patients